These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 37376061)

  • 1. Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma.
    Basu A; Namporn T; Ruenraroengsak P
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma.
    Lu Y; Gao Y; Yang H; Hu Y; Li X
    Mil Med Res; 2022 Dec; 9(1):69. PubMed ID: 36503490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting.
    Alhalmi A; Beg S; Kohli K; Waris M; Singh T
    Curr Drug Targets; 2021; 22(7):779-792. PubMed ID: 33302831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
    Sun J; Cheng M; Ye T; Li B; Wei Y; Zheng H; Zheng H; Zhou M; Piao JG; Li F
    Nanomedicine (Lond); 2022 Nov; 17(26):2037-2054. PubMed ID: 36789952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive-loaded nanodelivery systems for the feed and drugs of livestock; purposes, techniques and applications.
    Siddiqui SA; Bahmid NA; Taha A; Abdel-Moneim AE; Shehata AM; Tan C; Kharazmi MS; Li Y; Assadpour E; Castro-Muñoz R; Jafari SM
    Adv Colloid Interface Sci; 2022 Oct; 308():102772. PubMed ID: 36087561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib encapsulated in nanocarrier functionalized with glypican-3 specific peptide for targeted therapy of hepatocellular carcinoma.
    Feng S; Zhou J; Li Z; Appelman HD; Zhao L; Zhu J; Wang TD
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110498. PubMed ID: 31536939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma.
    Rodriguez S; Skeet K; Mehmetoglu-Gurbuz T; Goldfarb M; Karri S; Rocha J; Shahinian M; Yazadi A; Poudel S; Subramani R
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of nanoparticles in immunotherapy for hepatocellular carcinoma.
    Hu X; Zhu H; He X; Chen J; Xiong L; Shen Y; Li J; Xu Y; Chen W; Liu X; Cao D; Xu X
    J Control Release; 2023 Mar; 355():85-108. PubMed ID: 36708880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines: a theranostic approach for hepatocellular carcinoma.
    Usmani A; Mishra A; Ahmad M
    Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):680-690. PubMed ID: 28884605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib-Based Drug Delivery Systems: Applications and Perspectives.
    Wang L; Chen M; Ran X; Tang H; Cao D
    Polymers (Basel); 2023 Jun; 15(12):. PubMed ID: 37376284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-food-derived bioactives: Key health benefits and current nanosystems as a strategy to enhance their bioavailability.
    Salehi B; Rodrigues CF; Can Karaca A; Gülseren G; Şenol E; Demircan E; Özçelik B; Tutuncu S; Sharopov F; Sharifi-Rad J; Maroyi A; Martins N
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(4):232-242. PubMed ID: 32583797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging plant proteins as nanocarriers of bioactive compounds.
    Hadidi M; Tan C; Assadpour E; Kharazmi MS; Jafari SM
    J Control Release; 2023 Mar; 355():327-342. PubMed ID: 36731801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemical based nanomedicines against cancer: current status and future prospects.
    Rizwanullah M; Amin S; Mir SR; Fakhri KU; Rizvi MMA
    J Drug Target; 2018 Nov; 26(9):731-752. PubMed ID: 29157022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
    Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
    Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarrier-Based Tumor-Targeting Drug Delivery Systems for Hepatocellular Carcinoma Treatments: Enhanced Therapeutic Efficacy and Reduced Drug Toxicity.
    Tian T; Ruan J; Zhang J; Zhao CX; Chen D; Shan J
    J Biomed Nanotechnol; 2022 Mar; 18(3):660-676. PubMed ID: 35715919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma.
    Kong FH; Ye QF; Miao XY; Liu X; Huang SQ; Xiong L; Wen Y; Zhang ZJ
    Theranostics; 2021; 11(11):5464-5490. PubMed ID: 33859758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.